These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 7883578)

  • 41. Intercellular adhesion molecule, plasma adiponectin and albuminuria in type 2 diabetic patients.
    Lenghel AR; Kacso IM; Bondor CI; Rusu C; Rahaian R; Gherman Caprioara M
    Diabetes Res Clin Pract; 2012 Jan; 95(1):55-61. PubMed ID: 21945031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma osteoprotegerin concentrations in type 1 diabetic patients with albuminuria.
    Elsamahy MH; Elhenawy YI; Nawar MM
    J Diabetes Complications; 2015; 29(4):563-7. PubMed ID: 25744546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy.
    Watanabe H; Sanada H; Shigetomi S; Katoh T; Watanabe T
    Nephron; 2000 Sep; 86(1):27-35. PubMed ID: 10971150
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conformational mediated renal selectivity towards albumin in diabetes mellitus.
    Ghiggeri GM; Candiano G; Delfino G; Queirolo C
    Diabete Metab; 1986 Apr; 12(2):68-73. PubMed ID: 3721035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Revised criteria for the early diagnosis of diabetic nephropathy].
    Inomat S; Haneda M; Moriya T; Katayama S; Iwamoto Y; Sakai H; Tomino Y; Matsuo S; Asano Y; Makino H;
    Nihon Jinzo Gakkai Shi; 2005; 47(7):767-9. PubMed ID: 16296406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
    Shaker OG; Sadik NA
    Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic significance of urinary fibronectin in diabetic nephropathy.
    Kanauchi M; Nishioka H; Dohi K
    Nihon Jinzo Gakkai Shi; 1995 Feb; 37(2):127-33. PubMed ID: 7752504
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on urinary apolipoprotein H in diabetics].
    Yoshimoto Y; Takamatsu K; Yoshida K; Yamano T; Hashimoto K
    Nihon Jinzo Gakkai Shi; 1993 Mar; 35(3):209-15. PubMed ID: 8501849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platelet protein kinase C isoform content in type 2 diabetes complicated with retinopathy and nephropathy.
    Kimura M; Ishizawa M; Miura A; Itaya S; Kanoh Y; Yasuda K; Uno Y; Morita H; Ishizuka T
    Platelets; 2001 May; 12(3):138-43. PubMed ID: 11304414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Characteristics of the patients with diabetic nephropathy with relatively low serum creatinine at the initiation of dialysis].
    Nakao T
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1025-31. PubMed ID: 2263024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of tissue inhibitors of metalloproteinase in diabetic nephropathy.
    Kanauchi M; Nishioka H; Nakashima Y; Hashimoto T; Dohi K
    Nihon Jinzo Gakkai Shi; 1996 Mar; 38(3):124-8. PubMed ID: 8721333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Determinations of microproteinuria in early diabetic nephropathy].
    Kawanishi K; Ishida T; Kajikawa T; Tada S
    Rinsho Byori; 1995 May; 43(5):454-9. PubMed ID: 7783362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
    Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes.
    Suh JS; Kim SH; Cho KS; Jung IA; Cho WK; Jeon YJ; Jung MH; Suh BK
    Pediatr Nephrol; 2016 Apr; 31(4):623-31. PubMed ID: 26525196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy.
    Ellis D; Forrest KY; Erbey J; Orchard TJ
    Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients.
    Hamano K; Totsuka Y; Ajima M; Gomi T; Ikeda T; Hirawa N; Eguchi Y; Yamakado M; Takagi M; Nakajima H; Oda H; Seiki K; Eguchi N; Urade Y; Uehara Y
    Nephron; 2002 Sep; 92(1):77-85. PubMed ID: 12187088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of neopterin levels in patients undergoing hemodialysis.
    Asci A; Baydar T; Cetinkaya R; Dolgun A; Sahin G
    Hemodial Int; 2010 Apr; 14(2):240-6. PubMed ID: 20337742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.
    Fujita H; Morii T; Koshimura J; Ishikawa M; Kato M; Miura T; Sasaki H; Narita T; Ito S; Kakei M
    Endocr J; 2006 Dec; 53(6):745-52. PubMed ID: 16966829
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum beta 2-microglobulin as a index of the initiation of dialysis therapy for diabetic patients with chronic renal failure].
    Nakamura Y; Yasui A; Fukuda T; Yamamoto N; Ono T
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):983-7. PubMed ID: 1770630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Urinary neutrophil gelatinase-associated lipocalin in type 2 diabetes: Relation to nephropathy and retinopathy.
    Hosny SS; Bekhet MM; Hebah HA; Mohamed NR
    Diabetes Metab Syndr; 2018 Nov; 12(6):1019-1024. PubMed ID: 29960862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.